MR spectroscopy as a tool for in vivo determination of steatosis in liver transplant recipients

. 2011 Oct ; 24 (5) : 297-304. [epub] 20110710

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid21744232

OBJECT: Among several non-invasive methods of liver fat analysis, the most important role is played by MR imaging and spectroscopy (MRS). This study describes the 1H MRS at 3T measurement of liver fat volume fraction Φ(fat) in a group of liver transplant patients, an at-risk group for the development of de novo steatosis. MATERIALS AND METHODS: Seventy-seven liver transplant recipients who underwent routine protocolar posttransplant examination were divided into three groups: CON-PAT (control group for the cross validation test, 48 patients), PAT-PAT (patients test group for the cross validation test, 29 patients), and PAT (pooled data). Single voxel 1H MRS at 3T was used for the determination of Φ(fat) and histology results (His) were used as the reference standard. RESULTS: Linear and non-linear regression models were used to describe the relationship between Φ(fat) and His. Strong correlation was found for both models with r = 0.83-0.94 (P < 0.001); a higher r was found for non-linear regression in all tested groups. Areas under receiver operation curves were calculated for cut points His ≥ 5 and > 33% and were found in the range of 0.77-0.86. Fibrosis influences the calculation of Φ(fat) and different slopes were obtained for fibrosis stages F0-F1 and F2-F3, respectively. CONCLUSION: Significant correlation was found between the results of histology and 1H MRS measurement of liver fat content. The method is suitable for non-invasive repetitive examination of liver fat in liver-transplants patients between protocol biopsies and for the screening of steatosis in other liver diseases.

Zobrazit více v PubMed

World J Gastroenterol. 2010 Apr 7;16(13):1560-6 PubMed

Hepatology. 2005 Jun;41(6):1313-21 PubMed

Eur Radiol. 2009 Aug;19(8):2033-40 PubMed

J Clin Gastroenterol. 2010 Jan;44(1):58-65 PubMed

Am J Gastroenterol. 2010 Mar;105(3):621-3 PubMed

J Hepatol. 2009 Sep;51(3):433-45 PubMed

AJR Am J Roentgenol. 2008 May;190(5):1331-9 PubMed

Eur J Radiol. 2010 Jun;74(3):e60-6 PubMed

Eur Radiol. 2011 Jan;21(1):87-97 PubMed

Eur Radiol. 2009 Jul;19(7):1786-93 PubMed

J Hepatol. 2009 Aug;51(2):389-97 PubMed

Histopathology. 2006 Nov;49(5):450-65 PubMed

Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E462-8 PubMed

Radiology. 2009 Jan;250(1):95-102 PubMed

Br J Surg. 2010 Sep;97(9):1331-9 PubMed

Hepatology. 2002 Jun;35(6):1485-93 PubMed

Invest Radiol. 1993 Apr;28(4):297-302 PubMed

J Magn Reson Imaging. 2009 Aug;30(2):444-8 PubMed

J Magn Reson Imaging. 1995 May-Jun;5(3):281-5 PubMed

Am J Gastroenterol. 2010 Mar;105(3):613-20 PubMed

Transplantation. 1993 Apr;55(4):807-13 PubMed

Ann Surg. 2007 Jan;245(1):20-30 PubMed

Obesity (Silver Spring). 2010 Apr;18(4):841-7 PubMed

Gastroenterology. 2005 Jun;128(7):1898-906 PubMed

Magn Reson Imaging. 1994;12(3):487-95 PubMed

J Lipid Res. 2004 Jul;45(7):1364-71 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...